Unrevealing the Role of miRNA in Successful TNBC Treatment: A Pilot Study to Explore the Chemotherapy Drugs for Timely Treatment of TNBC
Objective Worldwide, breast cancer is the most prevalent and common type of cancer. Physical examination and mammography with a range of sensitivities are currently used as screening methods. Triple-negative breast cancer (TNBC) lacks estrogen receptor (ER), progesterone receptor (PR) and...
Main Authors: | Poulami Sarkar, Rashmi Chowdhary, Ashish Kumar Yadav, Neha Arya, Bharti Pandya, Vinay Kumar, Jagat R. Kanwar, Arshi Siddiqui, Roji Begum Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
|
Series: | Journal of Laboratory Physicians |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1774405 |
Similar Items
-
Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene
by: Yan Y, et al.
Published: (2019-05-01) -
Aptamer-Based Strategies to Boost Immunotherapy in TNBC
by: Lisa Agnello, et al.
Published: (2023-03-01) -
Optimization of Short RNA Aptamers for TNBC Cell Targeting
by: Simona Camorani, et al.
Published: (2022-03-01) -
TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors
by: Natalie Carroll, et al.
Published: (2022-11-01) -
Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
by: Aiswarya Chaudhuri, et al.
Published: (2022-04-01)